Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Cash Flows

v3.23.3
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Cash Flows from Operating Activities:    
Net Loss $ (33,397) $ (28,968)
Adjustments to Reconcile Net Loss to Cash Flows from Operating Activities:    
Depreciation and Amortization 19,758 20,905
Amortization of Deferred Financing Fees 2,148 0
Provisions for Non-Cash Losses on Inventory and Receivables 13,713 1,033
Equity-based Compensation Expense 5,603 5,178
Operating Lease Non-Cash Expense 3,816 4,568
Non-Cash Accrued 401K Contribution 3,773 3,300
Net Gain on Sale of Business, Before Taxes (3,427) (11,284)
Non-Cash Litigation Provision Adjustment (1,305) 2,000
Non-Cash Deferred Liability Recovery (5,824) 0
Other 911 2,997
Changes in Operating Assets and Liabilities Providing (Using) Cash:    
Accounts Receivable (12,980) (28,196)
Inventories (24,024) (35,444)
Accounts Payable 4,033 17,595
Accrued Expenses 5,111 935
Customer Advance Payments and Deferred Revenue (562) 1,990
Income Taxes 3,443 14,583
Operating Lease Liabilities (3,660) (5,715)
Supplemental Retirement Plan Liabilities (304) (306)
Other Assets and Liabilities 898 (4,312)
Net Cash Used by Operating Activities (22,276) (39,141)
Cash Flows from Investing Activities:    
Proceeds from Sale of Business and Assets 3,427 21,981
Capital Expenditures (6,037) (4,283)
Net Cash (Used) Provided by Investing Activities (2,610) 17,698
Cash Flows from Financing Activities:    
Proceeds from Long-term Debt 135,732 109,625
Principal Payments on Long-term Debt (125,984) (113,625)
Stock Award Activity 2,480 104
Proceeds from At-the-Market Stock Sales 13,045 0
Finance Lease Principal Payments (47) (85)
Debt Acquisition Costs (6,447) (968)
Net Cash Provided (Used) by Financing Activities 18,779 (4,949)
Effect of Exchange Rates on Cash (20) (797)
Decrease in Cash and Cash Equivalents and Restricted Cash (6,127) (27,189)
Cash and Cash Equivalents and Restricted Cash at Beginning of Period 13,778 29,757
Cash and Cash Equivalents and Restricted Cash at End of Period 7,651 2,568
Supplemental Disclosure of Cash Flow Information    
Non-Cash Investing Activities: Capital Expenditures in Accounts Payable $ 0 $ 1,392